AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
PREDICTIVE FACTORS INFLUENCING PEAK VIRAL LOAD DROP IN RESPONSE TO NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-5 IN ANTIRETROVIRAL-NAIVE HIV-1-INFECTED PATIENTS
Authors: VIDAL C GARCIA F GATELL JM LEAL M CLOTET B PUMAROLA T MIRO JM MALLOLAS J RUIZ L CRUCETA A TORTAJADA C
Citation: C. Vidal et al., PREDICTIVE FACTORS INFLUENCING PEAK VIRAL LOAD DROP IN RESPONSE TO NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR-5 IN ANTIRETROVIRAL-NAIVE HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(1), 1998, pp. 55-60
CHANGES IN HIV-1 RNA VIRAL LOAD FOLLOWING TUBERCULIN SKIN-TEST
Authors: GARCIA F VIDAL C GATELL JM MIRO JM CRUCETA A PUMAROLA T
Citation: F. Garcia et al., CHANGES IN HIV-1 RNA VIRAL LOAD FOLLOWING TUBERCULIN SKIN-TEST, Journal of acquired immune deficiency syndromes and human retrovirology, 18(4), 1998, pp. 398-399
PROTEASE INHIBITOR-ASSOCIATED HYPERINSULINEMIA
Authors: MARTINEZ E CASAMITJANA R CONGET I GATELL JM
Citation: E. Martinez et al., PROTEASE INHIBITOR-ASSOCIATED HYPERINSULINEMIA, AIDS, 12(15), 1998, pp. 2077-2079
LACK OF EVIDENCE OF A STABLE VIRAL LOAD SET-POINT IN EARLY-STAGE ASYMPTOMATIC PATIENTS WITH CHRONIC HIV-1 INFECTION
Authors: VIDAL C GARCIA F ROMEU J RUIZ L MIRO JM CRUCETA A SORIANO A PUMAROLA T CLOTET B GATELL JM
Citation: C. Vidal et al., LACK OF EVIDENCE OF A STABLE VIRAL LOAD SET-POINT IN EARLY-STAGE ASYMPTOMATIC PATIENTS WITH CHRONIC HIV-1 INFECTION, AIDS, 12(11), 1998, pp. 1285-1289
LACK OF T-CELL PROLIFERATIVE RESPONSE TO HIV-1 ANTIGENS AFTER 1 YEAR OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT IN EARLY HIV-1 DISEASE
Authors: PLANA M GARCIA F GALLART T MIRO JM GATELL JM
Citation: M. Plana et al., LACK OF T-CELL PROLIFERATIVE RESPONSE TO HIV-1 ANTIGENS AFTER 1 YEAR OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT IN EARLY HIV-1 DISEASE, Lancet, 352(9135), 1998, pp. 1194-1195
WHAT SHOULD BE DONE WHEN A PHYSICIAN IS A CARRIER OF THE HUMAN-IMMUNODEFICIENCY-VIRUS OF THE HEPATITIS-B OR HEPATITIS-C VIRUS
Authors: BRUGUERA M CAMPINS M ESTEBAN R GATELL JM MARTINEZ M NAVAS JJ ORTEGA D
Citation: M. Bruguera et al., WHAT SHOULD BE DONE WHEN A PHYSICIAN IS A CARRIER OF THE HUMAN-IMMUNODEFICIENCY-VIRUS OF THE HEPATITIS-B OR HEPATITIS-C VIRUS, Medicina Clinica, 111(2), 1998, pp. 61-66
RECOMMENDATIONS ON ANTIRETROVIRAL TREATME NT
Authors: MORENO S ARRIZABALAGA J GATELL JM CLOTET B AGUIRREBENGOA K ANTELA A IRIBARREN JA LAGUNA F MIRO JM OCANA I RUBIO R VICIANA P PODZAMCZER D
Citation: S. Moreno et al., RECOMMENDATIONS ON ANTIRETROVIRAL TREATME NT, Medicina Clinica, 110(3), 1998, pp. 109-116
CRYPTOCOCCUS AND SALMONELLA-OSTEOMYELITIS IN A PATIENT WITH AIDS
Authors: TORTAJADA C TORREGO A REVILLA M GARCIA F MIRO JM GATELL JM
Citation: C. Tortajada et al., CRYPTOCOCCUS AND SALMONELLA-OSTEOMYELITIS IN A PATIENT WITH AIDS, Revista Clinica Espanola, 198(6), 1998, pp. 403-404
INFLUENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS-1 INFECTION AND DEGREE OF IMMUNOSUPPRESSION IN THE CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS IN INTRAVENOUS-DRUG-USERS
Authors: RIBERA E MIRO JM CORTES E CRUCETA A MERCE J MARCO F PLANES A PARE JC MORENO A OCANA I GATELL JM PAHISSA A
Citation: E. Ribera et al., INFLUENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS-1 INFECTION AND DEGREE OF IMMUNOSUPPRESSION IN THE CLINICAL CHARACTERISTICS AND OUTCOME OF INFECTIVE ENDOCARDITIS IN INTRAVENOUS-DRUG-USERS, Archives of internal medicine, 158(18), 1998, pp. 2043-2050
PLEURAL AND PERITONEAL LEISHMANIASIS IN AN AIDS PATIENT
Authors: MUNOZRODRIGUEZ FJ PADRO S PASTOR P ROSARE D VALLS ME MIRO JM GATELL JM
Citation: Fj. Munozrodriguez et al., PLEURAL AND PERITONEAL LEISHMANIASIS IN AN AIDS PATIENT, European journal of clinical microbiology & infectious diseases, 16(3), 1997, pp. 246-248
CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS IN EUROPE
Authors: BURKE M YUST I KATLAMA C VARDINON N CLUMECK N PINCHING AJ LEDERGERBER B GATELL JM CHIESI A BARTON SE LUNDGREN JD PEDERSEN C
Citation: M. Burke et al., CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS IN EUROPE, European journal of clinical microbiology & infectious diseases, 16(12), 1997, pp. 876-882
LACK OF EMERGENCE OF GENOTYPIC RESISTANCE TO STAVUDINE AFTER 2 YEARS OF MONOTHERAPY
Authors: SORIANO V DIETRICH U VILLALBA N IMMELMANN A GILAGUADO A ECHEVARRIA S CLOTET B OCANA I SANTAMARIA JM BOUZA E BARONA V GATELL JM GONZALEZLAHOZ J
Citation: V. Soriano et al., LACK OF EMERGENCE OF GENOTYPIC RESISTANCE TO STAVUDINE AFTER 2 YEARS OF MONOTHERAPY, AIDS, 11(5), 1997, pp. 696-697
CYTOMEGALOVIRUS DISEASE IN HIV-1-INFECTED PATIENTS TREATED WITH PROTEASE INHIBITORS
Authors: MALLOLAS J ARRIZABALAGA J LONCA M GATELL JM ADAN A MARTINEZCHAMORRO E TORTAJADA C RODRIGUEZARRONDO F BLANCO A GUELAR A SORIANO E
Citation: J. Mallolas et al., CYTOMEGALOVIRUS DISEASE IN HIV-1-INFECTED PATIENTS TREATED WITH PROTEASE INHIBITORS, AIDS, 11(14), 1997, pp. 1785-1787
VIRAL LOAD IN ASYMPTOMATIC PATIENTS WITH CD4+ LYMPHOCYTE COUNTS ABOVE500X10(6) 1/
Authors: GARCIA F VIDAL C GATELL JM MIRO JM SORIANO A PUMAROLA T
Citation: F. Garcia et al., VIRAL LOAD IN ASYMPTOMATIC PATIENTS WITH CD4+ LYMPHOCYTE COUNTS ABOVE500X10(6) 1/, AIDS, 11(1), 1997, pp. 53-57
CHRONIC ENTEROPATHY OF UNKNOWN ETIOLOGY IN AIDS PATIENTS - ANALYSIS OF 40 CASES
Authors: CAMACHO AM MARTINEZ AM VALLS ME BORDAS JM PIQUE JM BOMBI JA MIRO JM MALLOLAS J GATELL JM SORIANO E
Citation: Am. Camacho et al., CHRONIC ENTEROPATHY OF UNKNOWN ETIOLOGY IN AIDS PATIENTS - ANALYSIS OF 40 CASES, Medicina Clinica, 109(12), 1997, pp. 452-456
SWITCHING FROM ZIDOVUDINE TO DIDANOSINE IN PATIENTS WITH SYMPTOMATIC HIV-INFECTION AND DISEASE PROGRESSION
Authors: GATELL JM GONZALEZLAHOZ J CLOTET B ANTUNES F KASPAROVA L GILAGUADO A SABALLS P SANTAMARIA JM PODZAMCZER D MIRO JM JOU A VERDEJO J DOROANA M THOMIS J BAQUERO F DEWIT S LEDEINE JM GOMEZ JJG BUIRA E POLO R SORIANO V BACHES MC GIMENEZ GS LAVILLA P CONZALEZ J RODRIGUEZ MCG DUPLA ML CARVALHO C FORTE M CALDEIRA L DUARTE N ZUBERO Z TEIRA R MUNOZ J SANTIN AC GUDIOL F IRIBARREN JA ARRIZABALAGA J ARRONDO FR GARDE C VIERNA SE ECHANOVE JA SANZ JS CEPEDA CS OCHAITA JC FERNANDEZCRUZ E ZABAY JM TRUJILLO FG ALDEGUER JL RODRIGO JL VAZQUEZ JMM NOVAL JM ELIAS MJP RUEDA LB DEMORA PM LOPEZ AA DONATE JMH ESTANY C FERRER MG DOMENECH MAS
Citation: Jm. Gatell et al., SWITCHING FROM ZIDOVUDINE TO DIDANOSINE IN PATIENTS WITH SYMPTOMATIC HIV-INFECTION AND DISEASE PROGRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 12(3), 1996, pp. 249-258
PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS
Authors: KATLAMA C DEWIT S ODOHERTY E VANGLABEKE M CLUMECK N PAYEN MC MATHIESEN L NIELSEN JO PEDERSEN C DUPONT B PIALOUX G JANBON F REYNES J GALLAIS H MARS ME JEANTILS V SCHNEIDER MC AVEROUS V DECAZES JM DOCOLECOMPTE T MODAI J MOLINA JM BLANC A DELFRAISSY JF GUILLEVIN L JARROUSSE B SEHOUANE R TROGOFF B ARMENGAUD M MARCHOU B MEURISSE JJ GENTILINI M GUICHARD A ROGEAUX O LIVROZET JM TOURAINE JL SERENI D ROUSSEAU F PESCE A COULAUD JP DETRUCHIS P FEGUEUX S MASLO C MATHERON S RAFFI F BASSETTI D CANESSA A DELBONO V DELEO P TERRAGNA A ANTINORI A DAMIANO F ORTONA L PALLAVICINI F TAMBURRINI E ANGARANO G CARBONARA S PASTORE G PORTEGIES P REISS P COSTA J MACHADO J MALTEZ F MORGADO A PROENCA R ANTUNES F CARVALHO C DOROANA M DUARTE N ARAUJO C CHAMPALIMAUD JL COSTA J MANSINHO K SEIXAS J LACRUZ J LOPEZALDEGUER J GATELL JM GUELAR A MALLOLAS J MIRO JM ZAMORA L CLOTET B JOU A RAVENTOS A ROMEU J SIRERA G BOLAO F CASANOVA A GUDIOL F PODZAMCZER D GAZAPO E GONZALEZLAHOZ JM BLANCO LM MORENO V POLO R MARTINEZ MC SANZ J VERDEJO J COSIN J MIRALLES P MORENO S PEREZTASCON O HIRSCHEL B PERRIER A RASSAERT C SOMMEREIJNS B UBRICH V BERLUREAU P DORMONT J LEVY JP MEUNIER F MIGNOLET F VANGLABEKE M VANPOTTELSBERGE C
Citation: C. Katlama et al., PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(2), 1996, pp. 268-275
TUBERCULOSIS AMONG EUROPEAN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
Authors: SUDRE P HIRSCHEL BJ GATELL JM SCHWANDER S VELLA S KATLAMA C LEDERGERBER B MONFORTE AD GOEBEL FD PEHRSON PO PEDERSEN C LUNDGREN JD
Citation: P. Sudre et al., TUBERCULOSIS AMONG EUROPEAN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME, Tubercle and lung disease, 77(4), 1996, pp. 322-328
HOME HOSPITALIZATION FOR AIDS PATIENTS - ONE-YEAR EXPERIENCE IN A UNIVERSITY HOSPITAL
Authors: GUELAR A GATELL JM CASADESUS C BORRAS N MALLOLAS J LAGUNA J SORIANO E
Citation: A. Guelar et al., HOME HOSPITALIZATION FOR AIDS PATIENTS - ONE-YEAR EXPERIENCE IN A UNIVERSITY HOSPITAL, AIDS, 10, 1996, pp. 99-99
THE INFLUENCE OF INTRAVENOUS DRUG-USE AND HIV-INFECTION IN THE TRANSMISSION OF TUBERCULOSIS
Authors: CAYLA JA DEOLALLA PG GALDOSTANGUIS H VIDAL R LOPEZCOLOMES JL GATELL JM JANSA JM
Citation: Ja. Cayla et al., THE INFLUENCE OF INTRAVENOUS DRUG-USE AND HIV-INFECTION IN THE TRANSMISSION OF TUBERCULOSIS, AIDS, 10(12), 1996, pp. 1446-1447
THE INFLUENCE OF INTRAVENOUS DRUG-USE AND HIV-INFECTION IN THE TRANSMISSION OF TUBERCULOSIS
Authors: CAYLA JA DEOLALLA PG GALDOSTANGUIS H VIDAL R LOPEZCOLOMES JL GATELL JM JANSA JM
Citation: Ja. Cayla et al., THE INFLUENCE OF INTRAVENOUS DRUG-USE AND HIV-INFECTION IN THE TRANSMISSION OF TUBERCULOSIS, AIDS, 10(1), 1996, pp. 95-100
PATIENTS WITH INFECTION BY HIV-1 - WHY AR E SOME SPRINTERS WHILE OTHERS ARE LIKE MARATHON RUNNERS
Authors: GATELL JM
Citation: Jm. Gatell, PATIENTS WITH INFECTION BY HIV-1 - WHY AR E SOME SPRINTERS WHILE OTHERS ARE LIKE MARATHON RUNNERS, Medicina Clinica, 107(20), 1996, pp. 776-778
IN-VITRO EFFECT OF THE HEROIN ON PERIPHER AL-BLOOD NEUTROPHIL POLYMORPHONUCLEAR LEUKOCYTES FUNCTION
Authors: SALA R MIRO JM FELIU E BIANCHI JL GATELL JM REVERTER JC SORIANO E SANMIGUEL JG
Citation: R. Sala et al., IN-VITRO EFFECT OF THE HEROIN ON PERIPHER AL-BLOOD NEUTROPHIL POLYMORPHONUCLEAR LEUKOCYTES FUNCTION, Medicina Clinica, 107(19), 1996, pp. 726-729
PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL
Authors: LEPORT C CHENE G MORLAT P LUFT BJ ROUSSEAU F PUEYO S HAFNER R MIRO J AUBERTIN J SALAMON R VILDE JL BLANC AP SCHMITT JL ARLAUD J ESTAVOYER JM GUILLEVIN L BENTATA M BEYLOT J LACUT JY GRANIER P COSNARD F BAZIN C DORMONT J REY M DELAUNAY C TROISVALLET D MICOUD M WEINBRECK P TREPO C GALLAIS H GASTAUT JA ALLARD C JANBON F CANTON P GROLLEAU JY CASSUTO J DELLAMONICA P DURET P FROTTIER J HERSON S SELIGMANN M SERENI D GIRAUDON BB DIEN G RUEL M STORCK D JAUBERT D LAFEUILLADE A MOUTON Y CHOUTET P LAFAIX C GATELL JM GUELAR A MILDVAN D SOIERO R JACOBSON JM MURRAY HW STEIGBIGEL NH SACHS HH VALENTINE F GRIECO MH ARMSTRONG D LEDERMAN M BARTLETT JA WASKIN HA NICHOLAS P FESSEL JW MACARTHUR RD GLATT AE PHAIR JP POWDERLY W HEWITT R STEIGBIGEL RT BLAIR DC SKAHAN KJ FRAME P CHEESEMAN SH CONNOR EM BALFOUR HH VANDERHORST C HO M
Citation: C. Leport et al., PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL, The Journal of infectious diseases, 173(1), 1996, pp. 91-97
EPIDEMIOLOGY AND OUTCOME OF PSEUDOMONAS-AERUGINOSA BACTEREMIA, WITH SPECIAL EMPHASIS ON THE INFLUENCE OF ANTIBIOTIC-TREATMENT
Authors: VIDAL F MENSA J ALMELA M MARTINEZ JA MARCO F CASALS C GATELL JM SORIANO E DEANTA MTJ
Citation: F. Vidal et al., EPIDEMIOLOGY AND OUTCOME OF PSEUDOMONAS-AERUGINOSA BACTEREMIA, WITH SPECIAL EMPHASIS ON THE INFLUENCE OF ANTIBIOTIC-TREATMENT, Archives of internal medicine, 156(18), 1996, pp. 2121-2126
Risultati: 1-25 | 26-50